S. Fattoum

发表

[Difference albumin-transferrin interest in the iron deficiency detection in a cohort of 1288 schoolchildren in the district of Tunis].

A. Torjman, H. Cherif, B. Zouari, 2006, Annales de biologie clinique.

Cystic fibrosis transmembrane conductance regulator mutation spectrum in patients with cystic fibrosis in Tunisia.

M. Claustres, M. des Georges, C. Templin, 2009, Genetic testing and molecular biomarkers.

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.

S. Perrotta, M. Cappellini, A. Piga, 2011, Blood.

MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES www.mjhid.org ISSN 2035-3006 Review article Evolution of Hemoglobinopathy Prevention in Africa: Results, Problems and Prospect

S. Fattoum, 2009 .

Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients

H. Siala, S. Fredj, F. Ouali, 2013, Molecular Biology Reports.

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia

H. Siala, T. Messaoud, S. Fredj, 2013, Clinical chemistry and laboratory medicine.

Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle cell disease and sickle cell thalassemia

H. Siala, T. Messaoud, S. Fredj, 2013, Clinical chemistry and laboratory medicine.

Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults

H. Siala, T. Messaoud, S. Hadj Fredj, 2012, Molecular Biology Reports.

An Electronic Infrastructure for Research and Treatment of the Thalassemias and Other Hemoglobinopathies: The Euro-Mediterranean Ithanet Project

A. Zafeiropoulos, F. Grosveld, R. Gambari, 2009, Hemoglobin.

Setup of a Protocol of Molecular Diagnosis of β‐Thalassemia Mutations in Tunisia using Denaturing High‐Performance Liquid Chromatography (DHPLC)

H. Siala, T. Messaoud, S. Hadj Fredj, 2016, Journal of clinical laboratory analysis.

Epidemiological profile of hemoglobinopathies in the Mauritanian population

V. Deyde, S. Fattoum, B. Ly, 2002, Annals of Hematology.

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.

S. Perrotta, P. Marks, M. Cappellini, 2006, Blood.

HbHope/HbS and HbS/β-thal double compound heterozygosity in a Mauritanian family: clinical and biochemical studies

V. Deyde, S. Fattoum, T. Aw, 2003, Annals of Hematology.

The erythrocyte effects of haemoglobin OARAB

R. Nagel, J. Elion, R. Krishnamoorthy, 1999, British journal of haematology.

Molecular Basis of β‐Thalassemia in the Population of Tunisia

A. Bibi, T. Messaoud, S. Fattoum, 2004 .

Contribution of β-globin cluster polymorphisms to raise fetal hemoglobin levels in normal adults

H. Siala, T. Messaoud, S. Hadj Fredj, 2012, Molecular Biology Reports.

[Hemoglobinopathies in Tunisia. An updated review of the epidemiologic and molecular data].

S. Fattoum, 2006, La Tunisie medicale.

α-Thalassaemia in Tunisia: some epidemiological and molecular data

H. Siala, F. Ouali, T. Messaoud, 2008, Journal of Genetics.

[Prenatal diagnosis of sickle cell anemia].

F. Zouari, T. Messaoud, S. Fattoum, 1994, La Tunisie medicale.

alpha-Thalassaemia in Tunisia: some epidemiological and molecular data.

H. Siala, F. Ouali, T. Messaoud, 2008, Journal of genetics.

First report of cystic fibrosis mutations in Libyan cystic fibrosis patients

T. Messaoud, S. Hadj Fredj, S. Fattoum, 2011, Annals of human biology.

[Molecular epidemiology of cystic fibrosis in Tunisia].

C. Férec, J. Elion, A. Bibi, 2005, Annales de biologie clinique.

Distribution of CFTR Mutations in Cystic Fibrosis Patients of Tunisian Origin: Identification of Two Novel Mutations

E. Denamur, C. Férec, J. Elion, 1996, European journal of human genetics : EJHG.

Point:Counterpoint: Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity

J. Lonsdorfer, P. Bogui, S. Fattoum, 2007 .

First Description in Tunisia of a Point Mutation at Codon 119 (CCT→TCT) in the α1-Globin Gene: Hb Groene Hart in Association with the − α3.7 Deletion

H. Siala, T. Messaoud, F. Ouali, 2005 .

First description in Tunisia of a point mutation at codon 119 (CCT-->TCT) in the alpha1-globin gene: Hb Groene Hart in association with the -alpha3.7 deletion.

H. Siala, T. Messaoud, F. Ouali, 2005, Hemoglobin.

The epidemiology of abnormal hemoglobins in Mediterranean high-level athletes

H. Siala, T. Messaoud, A. Bibi, 2010, European Journal of Applied Physiology.

Deferasirox (Exjade®, ICL670) Demonstrates Iron Chelating Efficacy Related to Transfusional Iron Intake in Pediatric Patients.

J. Ford, T. Klingebiel, Y. Kilinç, 2005 .

Glucose-6-phosphate dehydrogenase deficiency in Tunisia: molecular data and phenotype-genotype association

H. Siala, S. Hadj Fredj, F. Ouali, 2013, Molecular Biology Reports.

Point: Sickle cell trait should be considered asymptomatic and as a benign condition during physical activity.

J. Lonsdorfer, D. Le Gallais, P. Bogui, 2007, Journal of applied physiology.

Haplotypes Linked to Three Rare β-Thalassemia Mutations, Originally Reported in Tunisia

T. Messaoud, A. Bibi, S. Fattoum, 2006, Hemoglobin.

Association between clinical expression and molecular heterogeneity in β-thalassemia Tunisian patients

H. Siala, S. Fredj, F. Ouali, 2013, Molecular Biology Reports.

Detection of Two Rare β-Thalassemia Alleles Found in the Tunisian Population: Codon 47 (+A) and Codons 106/107 (+G)

C. Beldjord, T. Messaoud, A. Bibi, 2006, Hemoglobin.

Last Word on Point:Counterpoint “Sickle cell trait should/should not be considered asymptomatic and as a benign condition during physical activity”

J. Lonsdorfer, P. Bogui, S. Fattoum, 2007 .